News

Notification of a Potential Data Security Incident

Dear Madam/Sir: The Southern Illinois University School of Medicine, (“SIU”) is providing notice pursuant to 815 ILCS 530/25 in connection with an incident that may have involved the personal information of certain Illinois residents. This notice will be supplemented, if necessary, with any new significant facts discovered subsequent to its submission. While SIU is notifying you of this incident, SIU does not waive any rights or defenses relating to the incident or this notice. NATURE OF THE INCIDENT AND CORRECTIVE ACTIONS TAKEN SIU recently discovered that an unknown, unauthorized third party
Trial
Urology

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Active recruiting
The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma.
Trial
Neurology

A 6-month (stage 1) & 18-month (stage 2) prospective, randomized, placebo-controlled, doubleblind dual clinical trial investigating efficacy and safety of buntanetap in treating participants with early Alzheimer’s disease

Active recruiting
In this study, the safety and efficacy of buntanetap will be assessed in a diverse population of early AD participants via a randomized, double-blind, placebo-controlled, multicenter Phase 3 trial.
Trial
Neurology

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild to Moderate Alzheimer’s Disease (MINDSET 2)

Active recruiting
The purpose of this research is to learn if the experimental study drug KarXT + KarX-EC works to treat thinking and memory problems as well as improve overall function in people with Alzheimer’s disease (AD).
Subscribe to Research